[Bronchospasmolytic effect of adrenergic beta receptor agonists in bronchial asthma].
D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D004341:Drug Evaluation; D004983:Ethanolamines / Q000627:therapeutic use*; D005280:Fenoterol / Q000627:therapeutic use*; D006594:Hexoprenaline / Q000627:therapeutic use*; D006801:Humans; D009921:Metaproterenol / Q000627:therapeutic use*; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D010627:Phenethylamines; D005280:Fenoterol; D009921:Metaproterenol; D006594:Hexoprenaline
Bronkhospazmoliticheskoe deĭstvie stimuliatorov adrenergicheskikh beta-retseptorov pri bronkhial'noĭ astme